New Key Statistics Module, Z-Score and F-Score
SZSE:300233 Key Ratios
Market Cap ¥ M | 5,393.44 |
Enterprise Value ¥ M | 5,182.27 |
P/E(ttm) | 27.55 |
PE Ratio without NRI | 23.65 |
Forward PE Ratio | -- |
Price/Book | 1.46 |
Price/Sales | 1.54 |
Price/Free Cash Flow | 38.59 |
Price/Owner Earnings | -- |
Payout Ratio % | 0.51 |
Revenue (TTM) ¥ M | 3,484.00 |
EPS (TTM) ¥ | 0.51 |
Beneish M-Score | -2.76 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | 23.40 |
EV-to-EBIT | 19.46 |
EV-to-EBITDA | 19.46 |
PEG | -- |
Shares Outstanding M | 383.87 |
Net Margin (%) | 5.55 |
Operating Margin % | 8.15 |
Pre-tax Margin (%) | 7.06 |
Quick Ratio | 1.20 |
Current Ratio | 1.65 |
ROA % (ttm) | 3.32 |
ROE % (ttm) | 5.21 |
ROIC % (ttm) | 6.35 |
Dividend Yield % | 2.08 |
Altman Z-Score | 2.92 |
SZSE:300233 Number of Guru Trades
SZSE:300233 Volume of Guru Trades
Gurus Latest Trades with SZSE:300233
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300233 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Shandong Jincheng Pharmaceutical Group Co Ltd Insider Transactions
No Available Data